Jennifer Price
UCSF
Appearances
DateMay 7, 2023It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…Presenter
Virginia Commonwealth Univ.Speakers
- DateMay 8, 2023SOCIETY: DDW
Presenter
UCSF - DateMay 7, 2023BACKGROUND: Non-alcoholic steatohepatitis (NASH), a leading cause of liver-related morbidity and mortality, is highly prevalent in people living with HIV (PLWH).1 Microbial translocation (MT) associated with hepatic inflammation and fibrosis may play a critical role in NASH pathogenesis…
DateMay 19, 2024SOCIETY: AASLDModerators
DateMay 21, 2024SOCIETY: AGA Updates and newer management strategies for portal hypertension in patients with liver disease…Moderators
Rutgers The State University of New JerseyUCSF
